Clearing a way through the CRISPR patent jungle

Timo Minssen, Esther Van Zimmeren, Jakob Wested

2 results
- Date(ascending)

Why the GMO Regulations in Europe are ‘Not Fit for Purpose’
Timo Minssen
27/02/2019
1 Media contribution
Press/Media: Press / Media
Locus licenses CRISPR tech to Janssen in potential $818m deal
Timo Minssen
09/01/2019
1 Media contribution
Press/Media: Press / Media